Panbela Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 08 Nov 23 | SellUS$51,741 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 3,643.7 | US$14.20 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 0 | 0% |
| Institutions | 3 | 0.0000618% |
| Individual Insiders | 70 | 0.00144% |
| General Public | 4,854,788 | 100% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 8382%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 22 | US$8.4 | 0% | no data | |||
| 22 | US$8.4 | 0% | no data | |||
| 11 | US$4.3 | 0% | no data | |||
| 7 | US$2.6 | 0% | no data | |||
| 7 | US$2.6 | 0% | no data | |||
| 3 | US$1.1 | 0% | no data | |||
| 1 | US$0.4 | 0% | no data |